Intrapleural immunotherapy with escalati
โ
J. R. Viallat; C. Boutin; F. Rey; Ph Astoul; P. Farisse; M. Brandely
๐
Article
๐
1993
๐
John Wiley and Sons
๐
English
โ 396 KB
Background. The authors assessed the tolerance and efficacy of intrapleural interleukin-2 (IL-2) in patients with malignant effusion. Methods. Twenty-three patients had a total of 25 metastatic pleural effusions; the patients were treated with recombinant IL-2 by means of a continuous intrapleural